rasagiline

Generic: rasagiline

Labeler: torrent pharmaceuticals limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rasagiline
Generic Name rasagiline
Labeler torrent pharmaceuticals limited
Dosage Form TABLET
Routes
ORAL
Active Ingredients

rasagiline mesylate .5 mg/1

Manufacturer
Torrent Pharmaceuticals Limited

Identifiers & Regulatory

Product NDC 13668-447
Product ID 13668-447_6ec7578a-3b0b-4bee-b6cb-732421c9a89f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210150
Listing Expiration 2026-12-31
Marketing Start 2025-11-15

Pharmacologic Class

Classes
monoamine oxidase inhibitor [epc] monoamine oxidase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 13668447
Hyphenated Format 13668-447

Supplemental Identifiers

RxCUI
608328 636664
UPC
0313668447309 0313668446302
UNII
LH8C2JI290

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rasagiline (source: ndc)
Generic Name rasagiline (source: ndc)
Application Number ANDA210150 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .5 mg/1
source: ndc
Packaging
  • 500 TABLET in 1 CONTAINER (13668-447-05)
  • 30 TABLET in 1 CONTAINER (13668-447-30)
  • 90 TABLET in 1 CONTAINER (13668-447-90)
source: ndc

Packages (3)

Ingredients (1)

rasagiline mesylate (.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "6ec7578a-3b0b-4bee-b6cb-732421c9a89f", "openfda": {"upc": ["0313668447309", "0313668446302"], "unii": ["LH8C2JI290"], "rxcui": ["608328", "636664"], "spl_set_id": ["2c5e3cde-1158-4b5a-9a2b-ea6c987a65e4"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 CONTAINER (13668-447-05)", "package_ndc": "13668-447-05", "marketing_start_date": "20251115"}, {"sample": false, "description": "30 TABLET in 1 CONTAINER (13668-447-30)", "package_ndc": "13668-447-30", "marketing_start_date": "20251115"}, {"sample": false, "description": "90 TABLET in 1 CONTAINER (13668-447-90)", "package_ndc": "13668-447-90", "marketing_start_date": "20251115"}], "brand_name": "RASAGILINE", "product_id": "13668-447_6ec7578a-3b0b-4bee-b6cb-732421c9a89f", "dosage_form": "TABLET", "pharm_class": ["Monoamine Oxidase Inhibitor [EPC]", "Monoamine Oxidase Inhibitors [MoA]"], "product_ndc": "13668-447", "generic_name": "RASAGILINE", "labeler_name": "Torrent Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RASAGILINE", "active_ingredients": [{"name": "RASAGILINE MESYLATE", "strength": ".5 mg/1"}], "application_number": "ANDA210150", "marketing_category": "ANDA", "marketing_start_date": "20251115", "listing_expiration_date": "20261231"}